Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Chromosomal Triplication

3,4-methylenedioxyamphetamine has been researched along with Chromosomal Triplication in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Whitehall, JS1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Chromosomal Triplication

ArticleYear
The power of 13.
    The Medical journal of Australia, 2013, Dec-16, Volume: 199, Issue:11

    Topics: Bereavement; Chromosome Disorders; Chromosomes, Human, Pair 13; Family Relations; Female; Humans; In

2013